Research Article
Effects of Olanzapine on Bone Mineral Density, Glucose, and Lipid Metabolism in Schizophrenia Patients
Table 4
BMI-based subgroup analysis of biochemical and BMD characteristics in the olanzapine-treated group (
).
| | Normal weight () | Overweight () | Obesity () | | Multicomparison |
| TG (mmol/L) | | | | 0.030 | | CHOL (mmol/L) | | | | 0.241 | — | HDL (mmol/L) | | | | 0.162 | — | LDL (mmol/L) | | | | 0.851 | — | FBG (mmol/L) | | | | 0.001 | No, | Insulin (μU/mL) | | | | 0.041 | | BMD, radius+ulna (g/cm2) | | | | | | 1/3 | | | | 0.718 | — | MID | | | | 0.518 | — | UD | | | | 0.373 | — | TOTAL | | | | 0.583 | — | BMD, lumbar (g/cm2) | | | | | | L1 | | | | <0.001 | No, | L2 | | | | 0.001 | No, | L3 | | | | 0.009 | | L4 | | | | 0.818 | — | L1-4 | | | | 0.808 | — | BMD, left hip (g/cm2) | | | | | | NECK | | | | 0.004 | No, | TROCH | | | | 0.003 | No, | WARD | | | | 0.019 | | T-HIP | | | | <0.001 | |
|
|
Comparison of biochemical and BMD characteristics among the normal weight, overweight, and obesity subgroups. |